Flu Shot Clinic

Influenza (the flu) is a contagious respiratory illness that spreads easily and can cause serious health complications, particularly in young children and older adults. The virus spreads through the air when an infected person coughs, sneezes, or talks, as well as through contact with contaminated surfaces or objects.

• Symptoms may include sudden high fever, cough, muscle aches, headache, sore throat, fatigue, and loss of appetite. Nausea, vomiting, and diarrhea may also occur, especially in children.

• Flu Vaccine Availability: The influenza (flu) vaccine will be available starting October 8 for high-risk and priority populations and October 26 for the general public.

The influenza (flu) vaccine is available to high-risk and priority populations. Individuals who meet any of the following criteria are eligible for early vaccination:

High Risk Criteria:

• Residents of congregate living settings (such as chronic care facilities, long-term care homes, and retirement homes)

• Individuals 65 years of age and over*

• Pregnant individuals

• Children 6 months to 4 years of age

• Individuals in or from First Nations, Métis or Inuit communities

• Individuals 6 months of age and older with the following underlying health conditions:

  • Cardiac or pulmonary disorders

  • Diabetes mellitus or other metabolic disease

  • Cancer

  • Conditions or medication which compromise the immune system

  • Renal disease

  • Anemia or hemoglobinopathy

  • Neurologic or neurodevelopment conditions

  • Class 3 obesity (body mass index of 40 kg/m2 or more)

  • Children and adolescents (6 months to 18 years) undergoing treatment with acetylsalicylic acid for long periods

• Staff and care providers in congregate living settings (for example, chronic care facilities, long-term care homes, retirement homes)

• Health-care workers

• First responders

• Members of underserved communities

  • Individuals whose occupational or recreational activities increase their risk of exposure to avian influenza A viruses

    • Individuals with significant exposure to birds or mammals are more likely to have significant exposure to influenza A(H5N1) through interactions with birds or mammals (such as poultry, livestock, slaughterhouse and processing plant workers, wildlife officers/researchers, and veterinarians). Seasonal influenza vaccines do not provide protection against infection with influenza A(H5N1) viruses. However, they may reduce the risk of seasonal human and influenza A(H5N1) virus co-infection and possible viral reassortment leading to a human-transmissible virus with pandemic potential.

General Population: The flu vaccine will be available to the general public starting October 26, 2026.